Alzheimer Disease Clinical Trials in San Antonio, Texas

5 studies are recruiting for alzheimer disease in San Antonio, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

    The purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an immediate release (IR) capsule (KarXT) and xanomeline enteric capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who c…

    Stage
    Phase 3
    Ages
    55 to 90
    Site
    Local Institution - 2623, San Antonio, Texas
    Locations
    252 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT06937229 on ClinicalTrials.gov

  2. A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

    This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled, flexible-dose study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo in the treatment of psychosis in patients with AD.

    Stage
    Phase 2
    Ages
    55 and older
    Site
    University of Texas Health Science Center at San Antonio, San Antonio, Texas
    Locations
    67 in total
    Run by
    Intra-Cellular Therapies, Inc.

    See if you can join NCT06540833 on ClinicalTrials.gov

  3. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis related to AD.

    Stage
    Phase 3
    Ages
    55 to 90
    Site
    Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, San Antonio, Texas
    Locations
    293 in total
    Run by
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company

    See if you can join NCT06585787 on ClinicalTrials.gov

  4. Trial-Ready Cohort-Down Syndrome (TRC-DS)

    The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC), and up to 550 participants in total including co-enrolled in the Alzheimer Biomarkers Consortium - Down Syndrome (ABC-D…

    Stage
    Not phased
    Ages
    25 to 55
    Site
    University of Texas Health San Antonio, Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, San Antonio, Texas
    Locations
    22 in total
    Run by
    University of Southern California

    See if you can join NCT04165109 on ClinicalTrials.gov

  5. Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms

    Participants will be asked to participate in this research study of a device that creates transcranial direct current stimulation (tDCS). The researchers hope to learn if 30 minute sessions of transcranial direct current stimulation (tDCS) improve such a mood or feelings in people with Alzheimer's …

    Stage
    Not phased
    Ages
    60 to 85
    Site
    University of Texas Health Science Center at San Antonio, San Antonio, Texas
    Run by
    The University of Texas Health Science Center at San Antonio

    See if you can join NCT06801639 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.